Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...

EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b ...

Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today the first patient dosed in the VAN-2401 multi-center Phase 1 clinical trial evaluating ...

UNM scientists have developed a promising tau-targeting vaccine for Alzheimer’s, showing strong immune responses in animals ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research ...

Former NIH director Monica Bertagnolli and other scientists discussed the impact of reduced funding on cancer research and ...

HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a ...

This Phase III trial is based on a Phase I trial of patients in which the engineered cells were shown to be safe and effective, with minimal side effects. Initial study results were published April 9 ...

New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...